Minghui Pharmaceutical develops and distributes prescription medicines, with a focus on oncology, cardiology and infectious diseases.
Founded in 2018 and based in Shanghai, China, Minghui Pharmaceutical develops and distributes pharmaceutical products. Its portfolio includes prescription medicines for oncology, cardiology and infectious diseases, serving healthcare providers and patients. In August 2025, the company raised USD 131.00 mn in pre-IPO funding, with investors including OrbiMed Advisors and Qiming Venture Partners, to support clinical programs and commercialization preparation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in